上海济煜医药科技

Shanghai Jiyu Medical Technology is the dedicated research and development subsidiary of Jumpcan Pharmaceutical Group, focusing on the discovery and development of innovative therapies. The company operates across multiple technology platforms, including small molecule innovation, biologics, and advanced drug delivery systems such as liposomes and inhalations. Its therapeutic focus spans respiratory diseases, pain management, oncology, and metabolic disorders. By leveraging its parent company's manufacturing and commercialization strengths, Shanghai Jiyu aims to bridge the gap between early-stage research and large-scale clinical application. The company maintains a robust pipeline of both novel chemical entities and improved new drugs (505(b)(2) equivalent in China).